# 羅氏將繼續在德國彭茨貝格投資6億歐元建設新的診斷生產基地。

*biotech · news · 2026-06-09 · Reuters*

## Key points

- 羅氏將在德國彭茨貝格推進6億歐元的診斷生產基地投資。
- 在近期內閣決議後，羅氏計劃審慎檢視所有未來在德國的投資。
- 彭茨貝格項目是羅氏在德國最大單一投資，預計於2027年完成。
- 羅氏執行長警告，內閣決議增加了德國在研究、生產及投資方面的不確定性。

The company will continue its €600 million ($692.88 million) investment ​in a new diagnostic production site in ​Penzberg, Germany, Roche told Reuters. Sign up here. Roche said it would also now have to ​review its future investments in Germany carefully. The ​decision for Roche's investment in Penzberg, its largest single one ‌in ⁠Germany, was made several years ago, with construction expected to be completed by 2027. "The cabinet decision is creating a new degree of uncertainty ​regarding investments, research, ​and ⁠production decisions in Germany," Daniel Steiners, CEO of Roche Pharma AG, told ​Reuters. He added that the government risked ​causing significant ⁠economic damage with minimal benefit for a sustainable healthcare system, and said the parliamentary process now ⁠offered ​a final chance to ​keep Germany on a reliable path. ($1 = 0.8660 euros) Reporting by Patricia Weiss, ​writing by Marleen Kaesebier, editing by Linda Pasquini

**Companies:** Roche
**Countries:** Germany

[Read the full story on Reuters](https://www.reuters.com/business/healthcare-pharmaceuticals/roche-sticks-german-investment-after-eli-lilly-cuts-2026-06-09/)

---

Canonical: https://newsio.io/zh-TW/n/28979e3e-725e-4fcd-a47e-ea7b3502a48d/6
Summarized by Newsio from Reuters. https://newsio.io/how-it-works